Acadian Asset Management’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.61M | Buy |
528,559
+395,294
| +297% | +$5.69M | 0.02% | 487 |
|
|
2025
Q1 | $918K | Buy |
+133,265
| New | +$918K | ﹤0.01% | 957 |
|
|
2024
Q4 | – | Sell |
-10,430
| Closed | -$38K | – | 2251 |
|
|
2024
Q3 | $38K | Sell |
10,430
-2,835
| -21% | -$10.3K | ﹤0.01% | 1881 |
|
|
2024
Q2 | $35K | Sell |
13,265
-6,196
| -32% | -$16.3K | ﹤0.01% | 1637 |
|
|
2024
Q1 | $67K | Buy |
+19,461
| New | +$67K | ﹤0.01% | 1347 |
|
|
2023
Q1 | – | Sell |
-15,831
| Closed | -$26K | – | 2009 |
|
|
2022
Q4 | $26K | Buy |
+15,831
| New | +$26K | ﹤0.01% | 1679 |
|